Genetic Testing for the Prevention of Cancer in Indigenous American Communities (JUNIPER Trial)
Journey to Understanding - Indigenous Peoples Engagement in Cancer Research Arizona (JUNIPER)
Mayo Clinic
300 participants
Sep 27, 2024
INTERVENTIONAL
Conditions
Summary
This clinical trial is studying the genetic changes in cells associated with different types of cancer in Indigenous American (IA) populations in the Southwest to improve cancer screening, precision prevention, and therapeutic intervention for individual in these communities. IA tribes have much lower rates of cancer screening, have more limited access to healthcare, are more often diagnosed at later stages of disease, and have the poorest outcomes in all types of cancer when compared to any other racial and ethnic group in the United States. Due to these significant cancer health disparities, IAs have been understudied and little is known about the molecular characterization of tumors arising in IAs. Undergoing genetic testing of tumors may improve cancer outcomes in IA participants and communities.
Eligibility
Inclusion Criteria3
- Male or female adults >= 18 years of age
- Cancer patient undergoing active treatment or a cancer survivor
- Self-identify as Indigenous American
Exclusion Criteria3
- Unable to provide informed consent
- Individuals who are under 18 years of age
- Prisoners
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Undergo blood or saliva and leftover tissue sample collection
Receive care plan recommendations
Undergo genetic testing
Ancillary studies
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06569316